# Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF Therapy

> **NCT00811343** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 430 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** QFTB-G and T-SPOT.TB tests

## Key facts

- **NCT ID:** NCT00811343
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-12
- **Final completion:** 2012-06
- **Target enrollment:** 430 (ACTUAL)
- **Last updated:** 2014-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00811343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00811343, "Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00811343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*